polyketides are generated in vivo according to models of potential sporopollenin biosynthetic pathways [9] , even though these enzymes interact to form a biosynthetic metabolon in Nicotiana benthamiana [12] .
Saccharomyces cerevisiae offers a useful system for the expression of heterologous genes. Using sets of dual expression vectors with different selectable makers on plasmids, it is possible to express various combinations of genes in a single stain. This system allows for the reconstruction of plant natural product biosynthetic pathways in yeast [14, 16] . Unlike plants, which use the plastid as their fatty acid biosynthetic site, the yeast cell synthesizes fatty acids predominantly in the cytoplasm. The major fatty acids produced in yeast are palmitoleic acid (C16:1), palmitic acid (C16:0), oleic acid (C18:1), and stearic acid (C18:0), which are required to generate phospholipids for biological membranes [6] . Owing to the main location of fatty acid synthesis in yeast, malonyl-CoA (which is a building block to generate fatty acids) is ubiquitously present and easily available in the cytoplasm.
In vitro studies have shown that PKSA produces tri-and tetraketide α-pyrones by condensation of fatty acyl-CoAs with malonyl-CoAs [4, 7, 11, 13] and that TKPR1 reduces the keto function of tetraketide α-pyrone compounds synthesized by PKSA [9] . To determine the in vivo products generated by PKSA or/and TKPR1 using potential substrates present in a wild-type yeast strain (YPH499, genotype MATa ura3-52 lys2-801 ade2-101 trp-∆63 his3-∆200 leu2-∆1), PKSA, TKPR1, and PKSA/TKPR1 dual-expressing yeasts were generated. Each cDNA was cloned into the pESC-Ura or pESC-Leu vector (Agilent Technologies) under the control of the Gal1 promoter for PKSA and the Gal10 promoter for TKPR1. To validate the accumulation of PKSA and TKPR1 protein in PKSA/TKPR1 expressor, immunoblotting with PKSA and TKPR1 polyclonal antibodies (kindly provided from Dr. Michel Legrand [9] ) was performed and indicated that PKSA/TKPR1 dualexpressing yeast had both abundant PKSA and TKPR1 ( Fig. 2A) . To monitor metabolic alterations in yeast cells, the cell densities of each strain were measured after 24 h culture in synthetic minimal dropout medium lacking uracil or leucine. In the control strain and TKPR1 expressor, growth rates reached 5.12 ± 0.13 at OD 600 , whereas the growth rate of strains containing PKSA appeared abnormal. The PKSA expressor showed that it was close to the initial value, which was 0.40 ± 0.08 (OD 600 ) at 0 h. Moreover, the growth rate of the PKSA/TKPR1 expressor only reached up to 2.53 ± 0.10. These data suggest that accumulation of PKSA alone in yeast cells can result in metabolic change and repress growth rate.
To explore the potential products generated by the sporopollenin biosynthetic enzymes in the PKSA/TKPR1 expressor in vivo, total lipophilic compounds ranging from This image has been modified and adapted based on Kim and Douglas [10] . PKSA/B are the first committed enzymes of sporopollenin biosynthesis in Arabidopsis, yielding tri-and tetraketide α-pyrones. The tetraketide product is then reduced by TKPR1, which leads to polyhydroxyalkyl α-pyrone. (A) Immunoblot analysis by using polyclonal αPKSA or αTKPR1 antibody. PKSA and TKPR1 antibodies were pre-incubated overnight with an acetonic powder of S. cerevisiae to eliminate any nonspecific signal. For immunoblotting experiments, the procedures were as described previously [8] using antibodies at 1/10,000 dilution and a chemiluminescent substrate (Bio-Rad) for phosphatase activity detection. Lanes 1 and 3, vector control; Lanes 2 and 4, PKSA/TKPR1 dual expressor. (B) Total fatty acids in yeast cell extracts were transmethylated by adding 1 ml of methanolic-HCl and incubating at 80°C for 1 h. To obtain organic extracts, 1.5 ml of hexane was added followed by vortexing. The organic phases were pooled and evaporated under nitrogen gas. A total of six new compounds (A to F) were detected in the PKSA/TKPR1 expressor. Peaks 1-1, dodecanoic acid trimethylsilyl ether (C12); 2, 9-hexadecenoic acid methyl ether (C16:1); 2-1, 9-hexadecenoic acid trimethylsilyl ether (C16:1); 3, hexadecanoic acid methyl ether (C16); 3-1, hexadecanoic acid trimethylsilyl ether (C16); 4, 9-octadecenoic acid methyl ether (C18:1); 4-1, 9-octadecenoic acid trimethylsilyl ether (C18:1); 5, octadecanoic acid methyl ether (C18); 5-1, octadecanoic acid trimethylsilyl ether (C18); and 6, 9-hexanedioic acid 2,3-bis ester.
medium fatty acid (FA) derivatives to very long-chain FA derivatives were profiled by gas chromatography-mass spectrometry (GC-MS). To assay the FA metabolic profile in each strain, lipophilic compounds were extracted with hexane and then derivatized [19] . The FA derivatives were identified by comparing their GC-MS characteristics with literature data. In comparison with the TKPR expressor (data not shown) and the empty vector strain, PKSA/ For GC-MS analyses, the extraction from the reaction mixture, derivatization of organic compounds, and running condition of samples in GC-MS were previously described [19] , except for the following: the oven temperature was programmed for 2 min at 50°C, followed by a 40°C/min ramp to 120°C, held at 120°C for 2 min, increased by 2°C/min to 225°C, and held at 320°C for 10 min. Each mass spectrum has three common characteristic peaks at m/z 183, 198, and 211, together with different possible total molecular weights of 338, 366, 392, 394, 420, and 422, TKPR1 expressors exclusively generated a total of six unidentified compounds in the GC chromatograms (A to F in Fig. 2B ). Each peak had three fragments of the same characteristic masses (183, 198, and 211 m/z), while each peak had different total masses (338, 366, 392, 394, 420, and 422 m/z, respectively) (Fig. 3) . Since these novel peaks were present only in PKSA/TKPR1-expressing strains, they are likely to be polyketide products, supporting the presence of active PKSA enzymes in the strains even though they could not be identified in mass spectrum library and by the literature.
To identify novel products found in PKSA/TKPR1-expressing strains, the molecular weight for possible triketide and tetraketide α-pyrones was calculated and compared with the mass spectra. This result indicated that the chemical structures likely are triketide α-pyrone in these strains (Fig. 4) . This is consistent with previous in vitro studies suggesting that PKSA catalyzes the condensation of malonyl-CoA units with fatty acyl-CoAs of various chain lengths [4, 7, 11, 13] . Based on the total masses of the putative α-pyrone polyketides that accumulated, it appears that PKSA accepts C12:0, C14:0, C16:0, C16:1, C18:0, and C18:1 fatty acids in vivo to generate triketide α-pyrones.
Pentadecyl triketide α-pyrones, generated from condensation of C16:0 or C16:1 with malonyl-CoA, were the major products in these yeast strains, suggesting that C16 and C16:1 are preferable substrates for PKSA in vivo. Interestingly, although C12 and C14 fatty acid derivatives were not detected by GC in the PKSA/TKPR1 expressor, undecyl and tridecyl triketides α-pyrones generated by condensation reaction with C12 and C14, respectively, were present in this co-expressor (Fig. 2B ). This suggests that PKSA might have a higher affinity for medium chain fatty acyl-CoAs than acyl-CoA thioesterases catalyzing the hydrolysis of acyl-CoAs to the free acids and CoAs for further reaction.
The estimated molecular weights of triketides and tetraketides as well as the congruence of predicted and observed fragmentation patterns of triketide α-pyrones suggest that PKSA generated triketide α-pyrones rather than tetraketide α-pyrones (the TKPR1 substrate in vitro; [9] ). Moreover, no significant changes in the metabolite profiles were detected in strains expressing TKPR1, even though TKPR1 was clearly present in both soluble and in cell debris fractions of these strains (data not shown). The likely reason for the lack of TKPR1-specific products in these strains is that TKPR1 substrates were absent. We previously suggested that triketide α-pyrone corresponds to a derailment reaction product due to incomplete catalysis [11] . Thus, heterologously expressed Arabidopsis PKSA appears to perform only two rounds of condensation with malonyl-CoA in yeast cells, generating triketide α-pyrones that do not provide substrates for TKPR1. Interestingly, the total cell density at OD 600 was much lower in the PKSA expressor than in the PKSA/TKPR1 expressor. Under microscopy, PKSA expressors appear abnormal in morphology and devoid of budding daughter cells, showing that in vivo novel compounds generated by PKSA could inhibit cell growth or proliferation. These data indicate that TKPR1 could metabolize endogenous PKSA substrates into unknown products, making them less available for PKSA activity and resulting in restored yeast cell proliferation. Alternatively, the TKPR1 enzyme could act on the product generated by PKSA, leading to new compounds not detected in this metabolic profile. Altogether, our data suggest that yeast co-expressing PKSA and TKPR1 could be a platform strain to test the potential sporopollenin biosynthesis pathway in vivo.
